Who Owns Faeth Therapeutics Stock?
NASDAQ: FTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 80.94%
- Held by insiders
- 4.95%
- Institutional holders
- 61
- Institutions 80.9%
- Insiders 4.9%
- Public and other 14.1%
Who owns Faeth Therapeutics stock?
Institutional investors own about 80.9% of Faeth Therapeutics's shares, spread across 61 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.95% of FTH.
The largest institutional holders are Montanova Capital LLC (7.82%), Avoro Capital Advisors LLC (5.59%) and Baker Bros. Advisors, LP (4.98%). Together, the top 10 institutions control 40.0% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their FTH positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of FTH
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Montanova Capital LLC | 2.02M | 7.82% | +5747.1% |
| Avoro Capital Advisors LLC | 1.44M | 5.59% | +100.0% |
| Baker Bros. Advisors, LP | 1.29M | 4.98% | +100.0% |
| Balyasny Asset Management LP | 1.04M | 4.03% | +6331.3% |
| Cormorant Asset Management, LP | 1.03M | 3.98% | +235.8% |
| RA Capital Management, L.P. | 722.02K | 2.79% | +100.0% |
| Vivo Capital, LLC | 722.02K | 2.79% | 0.0% |
| Fairmount Funds Management LLC | 722.02K | 2.79% | +100.0% |
| Logos Global Management LP | 722.02K | 2.79% | +2306.7% |
| Caligan Partners, LP | 629.47K | 2.44% | +399.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of FTH
| Fund | Shares | % Held |
|---|---|---|
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 180.71K | 0.70% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 15.91K | 0.06% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 10.12K | 0.04% |
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 9.11K | 0.04% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 4.56K | 0.02% |
| iShares Trust-iShares Micro-Cap ETF | 3.17K | 0.01% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 1.42K | 0.01% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.25K | 0.00% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 210 | 0.00% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 41 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Faeth Therapeutics?
Montanova Capital LLC is the largest institutional shareholder of FTH, owning 7.82% of shares outstanding (2.02M shares) as of its latest 13F filing.
What percentage of Faeth Therapeutics is owned by institutions?
Institutions own about 80.9% of FTH shares and 85.1% of the public float.
How much of Faeth Therapeutics do insiders own?
Insiders, such as officers and directors, own about 4.95% of FTH shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.